{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:20Z","timestamp":1790710160396,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cangzhou Central Hospital Level Project","award":["YJ2024019"],"award-info":[{"award-number":["YJ2024019"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-003A"],"award-info":[{"award-number":["TJYXZDXK-3-003A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The zinc transporter SLC39A6, a member of the ZIP (Zrt-Irt-like protein) family, mediates zinc influx from the extracellular milieu into the cytosol and is indispensable for the function of numerous enzymes, transcription factors and signaling molecules. Previous studies have shown that SLC39A6 expression is associated with prognosis in esophageal squamous cell carcinoma and cervical cancer, indicating its potential impact on patient survival and tumor immunity. But a comprehensive pan-cancer analysis of SLC39A6 is still lacking. This study aimed to systematically delineate the oncogenic and prognostic relevance of SLC39A6 across multiple cancer types, to unravel its interplay with immune-infiltration patterns in the tumor micro-environment, and to preliminarily identify SLC39A6-associated therapeutic vulnerabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SLC39A6 expression profiles were retrieved from The Cancer Genome Atlas (TCGA) and cross-validated with GTEx, TIMER, HPA, cBioPortal, GEPIA2, STRING, KEGG, GO and other public repositories. Pan-cancer analyses were performed to characterize expression patterns, prognostic value, mutational landscape and functional networks. We further interrogated correlations between SLC39A6 and immune infiltration, tumor mutational burden (TMB), microsatellite instability (MSI) and immune-regulatory genes. Drug-sensitivity associations were evaluated using the CellMiner database, which facilitated molecular docking to predict binding poses and subsequent in vivo validation of lead compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SLC39A6 exhibited marked dysregulation across diverse tumor types and was significantly linked to patient survival. High SLC39A6 expression is associated with reduced overall survival and progression-free survival, particularly in cervical squamous cell carcinoma (CESC), as evidenced by studies that have analyzed the gene's expression and its impact on patient survival. Immune deconvolution revealed robust associations between SLC39A6 levels and the abundance of cytotoxic T cells, dendritic cells, macrophages and other immune subsets. CellMiner analyses demonstrated that increased levels of SLC39A6 resulted in enhanced sensitivity to the PI3K\u03b1 inhibitor CH5132799. Molecular docking studies predicted a strong affinity between CH5132799 and the zinc-binding pocket of SLC39A6, while mouse xenograft models further validated that CH5132799 effectively inhibited SLC39A6-mediated tumor growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SLC39A6 regulates the dynamics of immune infiltration and impacts prognosis in a wide range of malignancies. It emerges as a promising biomarker for prognosis, immunology, and therapy in the field of precision oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16063-6","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:55:57Z","timestamp":1779083757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity"],"prefix":"10.1186","volume":"26","author":[{"given":"Li","family":"Hongmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yufei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yuwei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dongqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mengjie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yudong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Jinghua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"3","key":"16063_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16063_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16063_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mc.23361","volume":"61","author":"RR Prasad","year":"2022","unstructured":"Prasad RR, Singh CK, Meng J, Nagamuga S, Satarug S. Stage-specific differential expression of zinc transporter SLC39A6 during tumorigenesis. Mol Carcinog. 2022;61(5):454\u201371. https:\/\/doi.org\/10.1002\/mc.23361.","journal-title":"Mol Carcinog"},{"key":"16063_CR4","doi-asserted-by":"publisher","unstructured":"Fukada T, Kambe T. Molecular and genetic features of zinc transporters in physiology and pathogenesis. Metallomics. 2011;3(7):662\u201374. https:\/\/doi.org\/10.1039\/c1mt00011j.","DOI":"10.1039\/c1mt00011j"},{"issue":"12","key":"16063_CR5","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1002\/jcp.30841","volume":"237","author":"R Saravanan","year":"2022","unstructured":"Saravanan R, Taylor KM, Brethour D. Zinc transporter LIV-1 (SLC39A6): a promising cell-surface target for triple-negative breast cancer. J Cell Physiol. 2022;237(12):4471\u201381. https:\/\/doi.org\/10.1002\/jcp.30841.","journal-title":"J Cell Physiol"},{"issue":"6","key":"16063_CR6","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1053\/j.gastro.2021.02.054","volume":"160","author":"MY Liu","year":"2021","unstructured":"Liu MY, Cui XB, Cheng XX, Zhao L, Chen W, Li X. SLC39A6 promotes aggressiveness of esophageal carcinoma by activating PI3K signaling via zinc influx. Gastroenterology. 2021;160(6):2228\u201340. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.054.","journal-title":"Gastroenterology"},{"issue":"4","key":"16063_CR7","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.18632\/aging.202640","volume":"13","author":"H Zhou","year":"2021","unstructured":"Zhou H, Wang J, Li Y, Zhang Y, Wang X, Li Z. Evaluation of the prognostic value of SLC39A6 in lung adenocarcinoma using TCGA data. Aging Albany NY. 2021;13(4):5312\u201327. https:\/\/doi.org\/10.18632\/aging.202640.","journal-title":"Aging Albany NY"},{"issue":"3","key":"16063_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/0109298665351592250106062250","volume":"32","author":"G Lyu","year":"2025","unstructured":"Lyu G, Li D. ZNF165: a pan-cancer biomarker with prognostic and therapeutic potential. Protein Pept Lett. 2025;32(3):206\u201323. https:\/\/doi.org\/10.2174\/0109298665351592250106062250.","journal-title":"Protein Pept Lett"},{"issue":"5","key":"16063_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/0115665232331353240911080642","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhao Z, Huang W, et al. Pan-cancer single-cell analysis revealing the heterogeneity of cancer-associated fibroblasts in skin tumors. Curr Gene Ther. 2025;25(5):793\u2013821. https:\/\/doi.org\/10.2174\/0115665232331353240911080642.","journal-title":"Curr Gene Ther"},{"key":"16063_CR10","doi-asserted-by":"publisher","unstructured":"Shi Y, Shen Q, Jiang A, et al. DrugSurvPlot: a novel web-based platform harnessing drug sensitivity scores as molecular biomarkers for pan-cancer survival prognosis. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232412138250722020114.","DOI":"10.2174\/0115665232412138250722020114"},{"issue":"4","key":"16063_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/0113892029291247240422060811","volume":"25","author":"M Jiang","year":"2024","unstructured":"Jiang M, Zhu D, Zhao D, et al. Integrated analysis of clinical outcome of mesenchymal stem cell-related genes in pan-cancer. Curr Genomics. 2024;25(4):298\u2013315. https:\/\/doi.org\/10.2174\/0113892029291247240422060811.","journal-title":"Curr Genomics"},{"issue":"8","key":"16063_CR12","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"16063_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"16063_CR14","unstructured":"Therneau TM. A package for survival analysis in R. R package version 3.4\u20130. 2022. https:\/\/CRAN.R-project.org\/package=survival."},{"issue":"3","key":"16063_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT Rich","year":"2010","unstructured":"Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010;143(3):331\u20136. https:\/\/doi.org\/10.1016\/j.otohns.2010.05.007.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"16063_CR16","doi-asserted-by":"publisher","first-page":"607622","DOI":"10.3389\/fonc.2020.607622","volume":"10","author":"B Xiao","year":"2020","unstructured":"Xiao B, Liu L, Li A, Liu J, Hu Z, Xiang D, et al. Identification and verification of immune-related gene prognostic signature based on ssGSEA for osteosarcoma. Front Oncol. 2020;10:607622. https:\/\/doi.org\/10.3389\/fonc.2020.607622.","journal-title":"Front Oncol"},{"key":"16063_CR17","doi-asserted-by":"publisher","first-page":"109903","DOI":"10.1016\/j.biopha.2020.109903","volume":"126","author":"D Xu","year":"2020","unstructured":"Xu D, Liu X, Wang Y, Li X, Zhang H, Wang J. Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile. Biomed Pharmacother. 2020;126:109903. https:\/\/doi.org\/10.1016\/j.biopha.2020.109903.","journal-title":"Biomed Pharmacother"},{"key":"16063_CR18","doi-asserted-by":"publisher","first-page":"831542","DOI":"10.3389\/fimmu.2022.831542","volume":"13","author":"R Chen","year":"2022","unstructured":"Chen R, Wu W, Chen SY, Chen X, Liu C, Chen L, et al. A pan-cancer analysis reveals CLEC5A as a biomarker for cancer immunity and prognosis. Front Immunol. 2022;13:831542. https:\/\/doi.org\/10.3389\/fimmu.2022.831542.","journal-title":"Front Immunol"},{"issue":"23","key":"16063_CR19","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-1501","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Zhang H, Jolly S, Luna A, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1501.","journal-title":"Cancer Res"},{"issue":"5","key":"16063_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"key":"16063_CR21","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","DOI":"10.1126\/scisignal.2004088"},{"issue":"D1","key":"16063_CR22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou KC, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"16063_CR23","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419\u201326. https:\/\/doi.org\/10.1093\/nar\/gky1038.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"16063_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"16063_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1471-2164-10-277","volume":"10","author":"UT Shankavaram","year":"2009","unstructured":"Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, Reinhold WC, et al. Cell Miner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics. 2009;10:277. https:\/\/doi.org\/10.1186\/1471-2164-10-277.","journal-title":"BMC Genomics"},{"key":"16063_CR26","doi-asserted-by":"publisher","unstructured":"Reinhold WC, Sunshine M, Varma S, Doroshow JH, Pommier Y. Using CellMiner 1.6 for systems pharmacology and genomic analysis of the NCI-60. Clin Cancer Res. 2015;21(17):3841\u20133852. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0335.","DOI":"10.1158\/1078-0432.CCR-15-0335"},{"issue":"3","key":"16063_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ol.2022.13197","volume":"23","author":"Z Wan","year":"2022","unstructured":"Wan Z, Wang X. Role of SLC39A6 in the development and progression of liver cancer. Oncol Lett. 2022;23(3):77. https:\/\/doi.org\/10.3892\/ol.2022.13197.","journal-title":"Oncol Lett"},{"issue":"1","key":"16063_CR28","doi-asserted-by":"publisher","first-page":"18275","DOI":"10.1038\/s41598-025-03713-1","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Liu W, Wu Y, Wang Y, Jiang Q, Li Y, et al. Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC. Sci Rep. 2025;15(1):18275. https:\/\/doi.org\/10.1038\/s41598-025-03713-1.","journal-title":"Sci Rep"},{"issue":"3","key":"16063_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10549-021-06336-y","volume":"189","author":"M Althobiti","year":"2021","unstructured":"Althobiti M, El-Sharawy KA, Joseph C, Aleskandarany M, Toss MS, Green AR, et al. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer. Breast Cancer Res Treat. 2021;189(3):621\u201330. https:\/\/doi.org\/10.1007\/s10549-021-06336-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"16063_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype\u2013immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"key":"16063_CR31","doi-asserted-by":"publisher","unstructured":"Zhou D, Lu P, Mo X, et al. Ferroptosis and metabolic syndrome and complications: association, mechanism, and translational applications. Front Endocrinol (Lausanne). 2024;14:1248934. https:\/\/doi.org\/10.3389\/fendo.2023.1248934.","DOI":"10.3389\/fendo.2023.1248934"},{"issue":"12","key":"16063_CR32","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1158\/1535-7163.MCT-13-0896","volume":"13","author":"D Sussman","year":"2014","unstructured":"Sussman D, Smith LM, Anderson ME, et al. SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer. Mol Cancer Ther. 2014;13(12):2991\u20133000. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0896.","journal-title":"Mol Cancer Ther"},{"key":"16063_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12967-015-0681-z","volume":"13","author":"XB Cui","year":"2015","unstructured":"Cui XB, Shen YY, Jin TT, et al. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma. J Transl Med. 2015;13:321. https:\/\/doi.org\/10.1186\/s12967-015-0681-z.","journal-title":"J Transl Med"},{"key":"16063_CR34","doi-asserted-by":"publisher","unstructured":"Qin X, Zhang J, Wang B, et al. Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Autophagy. 2021;17(12):4266\u20134285. https:\/\/doi.org\/10.1080\/15548627.2021.1911016.","DOI":"10.1080\/15548627.2021.1911016"},{"key":"16063_CR35","doi-asserted-by":"publisher","unstructured":"Bartos A, Sikora J. Bioinorganic modulators of ferroptosis: a review of recent findings. Int J Mol Sci. 2023;24(4):3634. https:\/\/doi.org\/10.3390\/ijms24043634.","DOI":"10.3390\/ijms24043634"},{"issue":"10","key":"16063_CR36","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1158\/1078-0432.CCR-10-2882","volume":"17","author":"H Tanaka","year":"2011","unstructured":"Tanaka H, Yoshida M, Tanimura H, Fujii T, Sakata K, Tachibana Y, et al. The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations. Clin Cancer Res. 2011;17(10):3272\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2882.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16063-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16063-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16063-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:02:58Z","timestamp":1784041378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16063-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16063"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16063-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and received approval from the ethics committee of the Institutional Animal Care and Use Committee of the Tianjin XINRUI (permit no. XinRui-DWLL-2025012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"841"}}